Neoadjuvant Immunoradiotherapy in Head & Neck Cancer

Conditions:   Head and Neck Cancer;   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Nivolumab;   Procedure: Surgical Resection;   Radiation: Radiation
Sponsors:   Providence Health & Services;   Providence Cancer Center, Earle A. Chiles Research Institute
Not yet recruiting - verified August 2017

http://ift.tt/2vBFSK0